Exploring Role For Neratinib Following Adjuvant Dual Targeted Her2 Therapy
Let's dive into the details surrounding Role For Neratinib Following Adjuvant Dual Targeted Her2 Therapy.
- Strategies demonstrated in the CONTROL trial can help mitigate the diarrhea associated with
- Sara M. Tolaney, MD, MPH, shares her recommendations for treating patients with
- ... think that's more the confluence of events of different trials showing the utility of different
- A key opinion leader shares insight on the management of adverse events seen with
- Mohammad Jahanzeb, MD, explains the optimal timing to start
In-Depth Information on Role For Neratinib Following Adjuvant Dual Targeted Her2 Therapy
Experts Debu Tripathy, MD, and Ruta D. Rao, MD, describe how to calculate the residual risk of recurrence Expert panelists evaluate the potential of Erika P. Hamilton, MD, director of the Breast and Gynecologic Research Program at Sarah Cannon Research Institute, discusses ... Panelists Adam M. Brufsky, MD, PhD; Michael Untch, MD; Hope S. Rugo, MD; Joyce A. O'Shaughnessy, MD; and Michael Gnant, ...
... our patients with early-stage
That wraps up our extensive overview of Role For Neratinib Following Adjuvant Dual Targeted Her2 Therapy.
